Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Ferrari

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Archives of Osteoporosis|March 4, 2017
Erratum to: Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fractureSerge Ferrari, Jean-Yves Reginster, Maria Luisa Brandi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2020
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOFJessica Pepe, Jean-Jacques Body, Peyman Hadji, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 24, 2020
T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH TrialFelicia Cosman, E Michael Lewiecki, Peter R Ebeling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 12, 2018
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture OutcomeFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
Arthritis and Rheumatism|November 1, 2006
Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal systemFabrizio De Benedetti, Nadia Rucci, Andrea Del Fattore, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 14, 2025
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosisLothar Seefried, Serge Ferrari, Dénes Páll, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 25, 2026
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phaseSerge Ferrari, Lothar Seefried, Dénes Páll, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2023
Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTSChristian Meier, Richard Eastell, Dominique D Pierroz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 29, 2022
Romosozumab efficacy and safety in European patients enrolled in the FRAME trialBente Langdahl, Lorenz C Hofbauer, Serge Ferrari, et al.
Journal of Clinical Medicine|May 4, 2026
Orthogeriatric Fracture Syndrome: A Large-Scale Bibliometric Analysis of a Proposed Concept for Cross-Disciplinary Awareness and Coordinated CareAlceu Bissoto, Heike Annette Bischoff-Ferrari, Karin Blum, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Archives of Osteoporosis|March 4, 2017
Erratum to: Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fractureSerge Ferrari, Jean-Yves Reginster, Maria Luisa Brandi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2020
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOFJessica Pepe, Jean-Jacques Body, Peyman Hadji, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 24, 2020
T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH TrialFelicia Cosman, E Michael Lewiecki, Peter R Ebeling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 12, 2018
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture OutcomeFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
Arthritis and Rheumatism|November 1, 2006
Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal systemFabrizio De Benedetti, Nadia Rucci, Andrea Del Fattore, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 14, 2025
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosisLothar Seefried, Serge Ferrari, Dénes Páll, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 25, 2026
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phaseSerge Ferrari, Lothar Seefried, Dénes Páll, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2023
Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTSChristian Meier, Richard Eastell, Dominique D Pierroz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 29, 2022
Romosozumab efficacy and safety in European patients enrolled in the FRAME trialBente Langdahl, Lorenz C Hofbauer, Serge Ferrari, et al.
Journal of Clinical Medicine|May 4, 2026
Orthogeriatric Fracture Syndrome: A Large-Scale Bibliometric Analysis of a Proposed Concept for Cross-Disciplinary Awareness and Coordinated CareAlceu Bissoto, Heike Annette Bischoff-Ferrari, Karin Blum, et al.
Pageof 18